SCHEMBL8486599

SCHEMBL8486599

CCc1ccc(CCC(=O)O)nc1NC

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ITGB3 P05106 2/20 0.35
ITGAV P06756 2/20 0.35
ITGB5 P18084 2/20 0.35
ITGB1 P05556 1/20 0.35
ITGA5 P08648 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
POLB P06746 1/20 0.35
KEAP1 Q14145 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MITF O75030 1/20 0.34
TP53 P04637 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
HDAC6 Q9UBN7 2/20 0.33
LTB4R Q15722 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22699771 0.71 TKT (0.33)
SCHEMBL30073942 0.71 ITGB3 (0.54) NPSR1ITGB3ITGAVITGB5ITGB1
SCHEMBL23455586 0.71 ITGB3 (0.54) NPSR1ITGB3ITGAVITGB5ITGB1
SCHEMBL21348071 0.71
SCHEMBL23341589 0.70 KCNH2 (0.43) HSD17B10ALDH1A1TP53TLR7
SCHEMBL6783633 0.68 KEAP1 (0.52) FFAR1NPSR1L3MBTL1KEAP1HDAC6
SCHEMBL3953029 0.67 NPSR1 (0.40) FFAR1NPSR1HSD17B10L3MBTL1POLB
SCHEMBL7611074 0.66 NPSR1 (0.52) FFAR1NPSR1HSD17B10L3MBTL1POLB
SCHEMBL22733678 0.66 CYP2C19 (0.50) FFAR1NPSR1POLBKEAP1FFAR4
SCHEMBL24248047 0.66 FFAR1 (0.53) FFAR1L3MBTL1POLBKEAP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506779-B1 (3-(4-(Pyridin-2-ylamino)-butyryl)-2,3,4,4a,9,9a-hexahydro-1H-3-aza-fluoren-9-yl)-acetic acid derivatives and related tricyclic indanyls as alphaVbeta3 and alphaVbeta5 integrin inhibitors for the treatment of cancer and unstable angina JANSSEN PHARMACEUTICA NV (BE) 2006-07-12 EP disclosed